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The natural human H-chain ferritin was expressed in E. coli using a multi-copy expression vector containing the d p,_ 
promoter. A variant H-ferritin, having an altered N-terminus, was also produced. These proteins are overproduced 
(> 30% of the soluble protein), correctly assembled into its 24~subunit shell, and able to bind iron. The identity of the 
products was confirmed using an antibody specific for H-ferritin. 
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1. INTRODUCTION 
Iron is of biological importance for a great many 
enzymatic reactions, but its availability is limited 
by the extremely low solubility of Fe(II1). In 
almost all organisms (animals, plants and 
bacteria), the problem of the insolubility of Fe(II1) 
is solved by ferritin. Ferritin is a large (450 kDa) 
iron-storage protein, which has the role of main- 
taining iron in a soluble, non-toxic and biologically 
available form. It consists of a mineral core of 
hydrated ferric oxide [Fe(III)O-OH] surrounded 
by a spherical protein coat of 24 subunits (apofer- 
ritin). Human ferritins consist of a combination of 
heavy (21 kDa) and light (19 kDa) chain apofer- 
ritin subunits in various proportions which can be 
tissue-specific (reviewed in [l]). Recently, the full- 
length cDNAs coding for the human ferritin H- 
chain and L-chain were cloned in E. coli and their 
nucleotide sequences determined [2-41. 
This report describes a strategy for the over- 
expression of the human ferritin H gene in E. coli. 
Such studies enable the production of ferritin com- 
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posed only of H-chain subunits and open the way 
for protein engineering on this molecule. 
2. MATERIALS AND METHODS 
Plasmid pFR3, containing the complete human ferritin H- 
chain cDNA was obtained from R. Cortese [2]. E. coli A pi ex- 
pression plasmid pAS1 and its host M5219 (carrying a ther- 
mosensitive ,! ~I857 repressor and a functional h N gene) were 
obtained from M. Rosenberg [5]. Plasmid pIC2OH containing 
a polylinker with multiple cloning sites was obtained from J.L. 
Marsh [6]. Plasmid pJRD184, which contains 49 unique restric- 
tion sites, has been described [7]. Recombinant DNA methods 
have been described in [8]. Enzyme-linked immunoassays using 
monoclonal antibodies for heart ferritin (H705) were kindly 
performed by M. Worwood (Cardiff), using the method of 
Flowers et al. [9]. Synthetic oligonucleotides were purchased 
from Eurogentech (Liege). 
3. RESULTS AND DISCUSSION 
Expression of a foreign gene in E. coli can be 
achieved by fusion of the cDNA coding sequence 
in-phase with the ATG codon of vector pAS1. In 
this vector, the X cI1 ATG codon is preceded by its 
own ribosome-binding site and is immediately 
followed by a BarnHI site to facilitate gene clon- 
ing. The E. coli host M.5219 carries a cryptic h pro- 
phage which provides the thermosensitive 
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repressor at 32°C and the h N gene product at 
42°C. This latter prevents termination of 
transcripts initiated at the pt. promoter of pAS1 
[5]. The in-phase fusion of the ATG initiator 
codon to the ferritin gene was accomplished as 
shown in fig. 1. The first (ATG), second and third 
codons of the ferritin cDNA gene were removed by 
digestion with TthlllI (fig.1). The 5’-protruding 
nucleotide was made blunt-ended by repair with 
DNA polymerase I Klenow fragment. The DNA 
was cleaved with PstI and the resulting 213 bp 
fragment subcloned between the EcoRV and PstI 
sites in the polylinker of pIC20H. This step locates 
a BgrII site just upstream of the EcoRV-7’thlllI 
junction. Fusion of this SfgII site, via its compati- 
ble sticky end, to the BarnHI site of pAS1 yields an 
in-phase fusion with the A cI1 initiator codon. The 
remainder of the ferritin gene was reconstituted by 
the addition of a 489 bp P&I-SphI fragment (SphI 
being located on the cDNA downstream of the fer- 
ritin termination codon). In ferritin expression vec- 
tor pDP219, the fusion maintains the 4th and all 
subsequent codons of natural ferritin: 
MetAspLeuAspAlaSerThr . . . recombinant H-ferritin 
MetThr Thr AlaSerThr . . . natural H-ferritin 
In a final step, the correct N-terminal sequence 
Tth 111 I Pst I 
Bg /II EcoR V Pst I 
A- ’ 
Pst I 
Bglll EcoRV Pst I 






I iPR cllrbs Ferrltin cDNA 




Nde I BspMl 
aq Ill EcoR I 
DDP 230 
PL 
nq rlL$ cllrbs Ferrrtln cDNA ApR 
Fig. 1. Construction of H-ferritin expression plasmid pDP219. The repaired Tthll lI-Pstl fragment (D) of H-ferritin cDNA clone pFR3 
(C) was cloned between the EcoRV-Pstl sites of pIC2OH (A), thereby positioning a Bg/II site just upstream of the ferritin gene fragment 
(F). This BglII site was ligated to the BarnHI-Sphl cleaved pASl and the pDP219 recombinant plasmid (C) was completed by addition 
of the 3’-end of the ferritin cDNA on a fstl-SphI fragment (E). The plasmid pDP219 (G) carries the ferritin cDNA in-phase with 
the ATG codon of the h cl1 gene of pAS1, but its N-terminus is different to that of native ferritin. A synthetic DNA fragment (H) 
was used to restore the native N-terminal sequence between the NdeI and BspMI sites of pDP219. The final plasmid pDP230 (I) carries 
the complete ferritin cDNA. Symbols: 0, polylinker DNA of pIC19H; I, coding region of the H-ferritin cDNA; U, non-coding 
region of H-ferritin cDNA; ~, pAS1 DNA (the plasmid is drawn as if linearized at its unique EcoRI site); pr, lambda leftward 
promoter; nutr and nuts. sites of utilization of theh N gene product [5]; cIIrbs, ribosome-binding site of theh cI1 gene; ApR, resistance 
to ampicillin; ‘, denotes the loss of a previously existing restriction site. 
62 
Volume 234, number 1 FEBS LETTERS 
was restored by the use of a synthetic DNA se- 
quence, 17 bp long, defined at its 5 ‘-end by an 
NdeI site and at its 3 ‘-end by a BspMI site. This 
DNA fragment was used to substitute the sequence 
between the NdeI site (1 bp upstream of the ATG 
codon) and the BspMI site (12 bp downstream of 
the ATG codon) of pDP219. To do this, the 
oligomer was first joined to a 243 bp BspMI- 
EcoRV ferritin fragment in the restriction site 
bank vector pJRD184 cleaved with NdeI and 
EcoRV. The resulting plasmid was then cleaved 
with NdeI and EcoRV, and the 260 bp fragment 
subcloned between the NdeI and EcoRV sites 
pDP219 in a triple ligation using an intermediate 
Bg/II site; this step is necessary because of the 
multiple NdeI sites in pAS1. This ferritin expres- 
sion vector was named pDP230. 
The ability of the ferritin clones to express H- 
chain ferritin was investigated by temperature in- 
duction (4 h) of the cryptic A ~1857 lysogen M5219, 
followed by SDS-polyacrylamide gel elec- 
Fig.2. Electrophoresis in an SDS-17.5% polyacrylamide gel of 
polypeptides made from E. co/i M5219 containing pDP219 or 
pDP230. Cultures of M5219 containing pDP219 (lanes 2,3) or 
pDP230 (lanes 4,5) were grown at 32 and 42”C, respectively. 
Only whole cell extracts are shown. Lane 1 contains molecular 
mass markers (Amersham Rainbow proteins: 14.3, 21.5, 30.0, 
46.0, 69.0, 92.5 and 200 kDa from bottom to top of the gel). 
The apoferritin band is indicated by an arrow. 
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Fig.3. Electrophoresis in a 6% polyacrylamide gel of soluble 
proteins (extracted by sonication and centrifugation) of E. co/i 
MS219 containing pDP219 or pDP230. (A) Samples extracted 
from cultures of M5219 containing pDP219 or pDP230, grown 
at 32°C (lanes 2.3, respectively) and at 42°C (lanes 4,5, 
respectively) and stained with Coomassie blue. (B) Prussian 
blue staining of the 42°C cultures of M5219 containing pDP219 
or pDP230 (lanes 6,7, respectively). Lanes 8,9 contain the same 
samples, pretreated with ferrous ammonium sulfate. Lanes I, 10 
contain molecular mass markers (Pharmacia high molecular 
mass calibration kit: 232, 440 [horse spleen ferritin] and 
669 kDa, from bottom to top of the gel). The band staining 
with Prussian blue in lane 10 is the horse spleen ferritin. 
trophoresis. The results (fig.2) show that pDP219 
and pDP230 code for a polypeptide of 21 kDa, 
corresponding to the known size of H-chain 
apoferritin. This protein comprised >20% of the 
total protein, and >30% of soluble protein, as 
determined by densitometry of the Coomassie- 
blue-stained gel. Non-denaturing gels (fig.3A) in- 
dicate that the H-chain subunits are correctly 
assembled into complete ferritin (& 450 kDa); 
however, the pDP21Pferritin migrates somewhat 
faster than pDP230-ferritin, probably because of 
the increased positive charge due to the 2 aspartic 
acid residues at the N-terminus. 
The ability to bind iron was verified by staining 
the gel with Prussian blue (fig.3B). The recombi- 
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nant ferritins contain little iron, as judged by the 
weak staining. However, when soluble cell extracts 
had been preincubated with 1 mM ferrous am- 
monium sulfate, a dense Prussian blue stained 
band appeared, indicating that the recombinant 
ferritins are able to take up iron from the medium. 
The identity and the quantity of the over-expressed 
protein as H-ferritin were also confirmed by using 
a monoclonal antibody specific for H-ferritin. 
These assays indicate that ferritin comprises about 
35% of the soluble protein of E. coli. Recently, 
similar results on the synthesis of H-ferritin in E. 
coli, using a different construction method, have 
been reported [lo]. 
These results open the way for the production of 
large quantities of this rare human protein for use 
in structural studies involving X-ray crystallog- 
raphy and protein engineering. 
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